Researchers find weakness in hep C virus

Researchers from the University of New South Wales say they've discovered not one but two "Achilles heels" within the hepatitis C virus. The diseases' first weak point is in transmission, when it must move from person to person. The second comes three months after infection; the number of viral variants drops as the immune system responds, providing a window that may make it easier to target the virus. Article

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.